HEALTHPARTNERS RES & EDUCATION has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and foods and drinks are NEVAKAR INC, HALLUX INC and BLAISE GILBERT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Foods and drinks | |
#4 | Furniture and games | |
#5 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Hairstyling and cosmetic | |
#5 | Household appliances | |
#6 | Object sterilising | |
#7 | Enzymes | |
#8 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Frey Ii William H | 11 |
#2 | Bresin Hanson Leah Ranae | 9 |
#3 | Brabazon Fiona | 8 |
#4 | Byrnes Kimberly | 8 |
#5 | Frey William H Ii | 3 |
#6 | Frey William H | 1 |
#7 | Jacobs Daniel I | 1 |
#8 | Kang Matthew M | 1 |
#9 | William H Frey Ii | 1 |
#10 | Yeomans David C | 1 |
Publication | Filing date | Title |
---|---|---|
US2015283065A1 | Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin | |
WO2015066414A1 | Methods of treating corticobasal degeneration comprising administering metal chelators to the upper one-third of the nasal cavity | |
US2014255384A1 | Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin | |
US2014031280A1 | Methods for preventing and treating post-traumatic stress disorder (PTSD) | |
US2013336928A1 | Methods and pharmaceutical compositions for treatment of central nervous system disorders with therapeutic agent(s) in patients with concurrent non-cns condition(s) or disorders contraindicating systemic administration of the therapeutic agent(s) | |
US2014046273A1 | Antibiotic delivery system and method | |
US2013096488A1 | Methods for using ultrasound for enhancing efficiency and targeting of intranasal administration of therapeutic compounds to the central nervous system |